Jul 2026· Brain : a journal of neurology· 0 citations
Medicine
TL;DR
It is proposed movement execution during dyskinesia should be considered as a distinct behavioral and neural microstate within a dopamine-depending hyperdopaminergic macrostate within a dopamine-depending hyperdopaminergic macrostate to inform future adaptive neuromodulation and enhance its naturalistic robustness during every-day life.
Abstract
Parkinson patients suffer from levodopa-induced dyskinesia, which occur adversely to chronic dopaminergic treatment. These abnormal involuntary movements can only partly be actively suppressed and affect quality of life. A lowered motor inhibition during hyperdopaminergic states, associated with structural and plasticity changes in the cortico-basal-ganglia motor network, is hypothesized to enable dyskinesia. Multiple oscillatory cortico-subthalamic patterns associated with dyskinesia have been described but their dependence on behavioral states such as movement presence remains unknown, which is crucial for its use in real-life application of adaptive neuromodulation. We studied invasive cortico-subthalamic oscillations in 22 patients with Parkinson's disease during dyskinesia-evoking protocols. Clinical assessments differentiated between non-dyskinetic and dyskinetic periods, and kinematic monitoring detected movement presence, leading to four behavioral states containing rest, voluntary movements, movement suppression during dyskinesia, and dyskinetic movements. Data-driven methods reduced data dimensionalities and optimized frequency-specific signal-to-noise ratios in the neural recordings and allowed feature extraction of spectral magnitudes, variances, and inter-subthalamic and cortico-subthalamic coherences. Subthalamic theta-activity and attenuated beta-activity were elevated during both dyskinetic movement suppression and execution, while cortico-subthalamic gamma-activity was only increased during dyskinetic movement execution. The subthalamic oscillations predicted dyskinesia presence, but varying behavioral states containing fluctuating movement presence affected the predictive performance. Movement-aware classifications improved dyskinesia detection based on cortical and on gamma oscillations. Introducing a movement-aware classification which considered the current behavioral state improved the neural detection of therapeutic states. We propose movement execution during dyskinesia should be considered as a distinct behavioral and neural microstate within a dopamine-depending hyperdopaminergic macrostate. Integrating this state concept may inform future adaptive neuromodulation and enhance its naturalistic robustness during every-day life.
Levodopa is the gold-standard treatment for Parkinson's disease, but chronic use results in levodopa-induced dyskinesia (LID) in approximately 80% of patients. Previous research has identified critical network changes in the cortico-basal ganglia pathway associated with LID; however, no study has extensively recorded m...
L. Bentall, L. Parr-Brownlie· Neuroscience· 0 citations
Bradykinesia is a cardinal motor feature of Parkinson’s disease and is characterised by a reduced ability to generate movements with normal speed and force. Although nigrostriatal dopamine loss is regarded as the primary cause, direct human evidence linking dopaminergic degeneration to striatal dysfunction and impaired...
B. L. C. Thomsen, V. Labanauskas, N. Raaf et al.· bioRxiv· 0 citations
OBJECTIVE
Traditional analyses of subthalamic nucleus local field potentials (STN-LFPs) may obscure relevant dynamics by conflating periodic and aperiodic activity. We investigated whether spectral parameterization reveals phenotype- and movement-dependent neural signatures in Parkinson's disease (PD).
METHODS
Intrao...
Luiz R. T. da Silva, M. Rocha, Arnaldo F. Neto et al.· Parkinsonism & Related Disor...· 0 citations
BACKGROUND
Parkinson's disease (PD) bradykinesia is a complex of motor abnormalities. Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) and L-dopa both improve bradykinesia, but their differential effects on each component remain unknown.
OBJECTIVE
To quantify and compare the differential effects of STN-DBS and L-...
D. S. Marín-Medina, Miguel Wilken, F. Wainberg et al.· Movement Disorders Clinical...· 0 citations
In unconstrained, daily activities, mDBS lowered average bradykinesia severity and demonstrated progressive symptom reduction over hours of therapy, which gradually reversed upon switching to cDBS, highlighting the enhanced therapeutic benefit of mDBS and its potential to reinforce functional motor circuits in disorder...
D. Lawrence, J. Suh, V. Chang et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.